(Q41147370)

English

Generation of tumor-specific cytolytic T lymphocytes from peripheral blood of cervical cancer patients by in vitro stimulation with a synthetic human papillomavirus type 16 E7 epitope

scientific article published on December 1996

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

27 September 2017

Generation of tumor-specific cytolytic T lymphocytes from peripheral blood of cervical cancer patients by in vitro stimulation with a synthetic human papillomavirus type 16 E7 epitope (English)

1 reference

Europe PubMed Central

PubMed publication ID

27 September 2017

Alessandro Sette

4

object named as

Sette A

1 reference

Europe PubMed Central

PubMed publication ID

27 September 2017

author name string

Alexander M

1

1 reference

Europe PubMed Central

PubMed publication ID

27 September 2017

Salgaller ML

2

1 reference

Europe PubMed Central

PubMed publication ID

27 September 2017

Celis E

3

1 reference

Europe PubMed Central

PubMed publication ID

27 September 2017

Barnes WA

5

1 reference

Europe PubMed Central

PubMed publication ID

27 September 2017

Rosenberg SA

6

1 reference

Europe PubMed Central

PubMed publication ID

27 September 2017

Steller MA

7

1 reference

Europe PubMed Central

PubMed publication ID

27 September 2017

language of work or name

0 references

publication date

1 December 1996

1 reference

Europe PubMed Central

PubMed publication ID

27 September 2017

American Journal of Obstetrics and Gynecology

1 reference

Europe PubMed Central

PubMed publication ID

27 September 2017

175

1 reference

Europe PubMed Central

PubMed publication ID

27 September 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

27 September 2017

1586-1593

1 reference

Europe PubMed Central

PubMed publication ID

27 September 2017

Estimates of the worldwide mortality from eighteen major cancers in 1985. Implications for prevention and projections of future burden

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2896%2970110-2

7 January 2021

Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2896%2970110-2

7 January 2021

Continued expression of HPV-16 E7 protein is required for maintenance of the transformed phenotype of cells co-transformed by HPV-16 plus EJ-ras.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2896%2970110-2

7 January 2021

Behavior of mild cervical dysplasia during long-term follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2896%2970110-2

7 January 2021

Human immunodeficiency virus infection and cervical neoplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2896%2970110-2

7 January 2021

The structure of HLA-B27 reveals nonamer self-peptides bound in an extended conformation

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2896%2970110-2

7 January 2021

Vaccination with cytotoxic T lymphocyte epitope-containing peptide protects against a tumor induced by human papillomavirus type 16-transformed cells

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2896%2970110-2

7 January 2021

Structure and transcription of human papillomavirus sequences in cervical carcinoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2896%2970110-2

7 January 2021

Human papillomavirus types 16 and 18 sequences in carcinoma cell lines of the cervix

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2896%2970110-2

7 January 2021

Expansion of human tumor infiltrating lymphocytes for use in immunotherapy trials

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2896%2970110-2

7 January 2021

A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2896%2970110-2

7 January 2021

Identification of the immunodominant peptides of the MART-1 human melanoma antigen recognized by the majority of HLA-A2-restricted tumor infiltrating lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2896%2970110-2

7 January 2021

Induction of anti-tumor cytotoxic T lymphocytes in normal humans using primary cultures and synthetic peptide epitopes

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2896%2970110-2

7 January 2021

Identification of human cancers deficient in antigen processing

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2896%2970110-2

7 January 2021

Identifiers

10.1016/S0002-9378(96)70110-2

1 reference

Europe PubMed Central

PubMed publication ID

27 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

27 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41147370&oldid=1915991696"